Management

  • team

    Ulf Jungnelius

    Ulf has been a director of Isofol since 2010 and has been its clinical and regulatory expert. He has a…

    by
  • team

    Tony Gustavsson

    Tony Gustavsson leads the licensing and commercialization efforts of the company’s lead drug candidate arfolitixorin. Prior to joining Isofol, Mr.…

    by
  • Roger Tell
    team

    Roger Tell, MD, PhD

    Dr. Roger Tell is responsible for medical and scientific issues at Isofol. Dr. Tell joined Isofol in February 2019 and…

    by
  • Gustaf Albèrt
    team

    Gustaf Albèrt, MSc

    Gustaf is a business-oriented economist with broad financial and operational experience. He is responsible for the company’s financial management and…

    by